ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
일차 세포 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 10.0%로 24억 4,000만 달러로 성장합니다. 예측 기간의 성장은 맞춤형 의료에 대한 수요 증가, 줄기세포 연구에 대한 관심 증가, 투자 증가, 세포 기반 분석법 채택 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 인간 1차 세포에 대한 수요, 연구 툴 및 기술 발전, 세포 기반 치료법의 채택 등이 있습니다.
향후 5년간의 성장률을 10.0%로 예측한 것은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 영국과 캐나다에서 수입되는 고품질 1차 세포주 비용을 상승시키고, 의약품 개발 일정에 차질을 빚을 수 있으며, 연구비를 상승시켜 미국의 생물의학 연구에 혼란을 초래할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
암 연구에 대한 정부 자금 증가는 향후 1차세포 시장의 성장을 가속할 것으로 예측됩니다. 자금 지원은 프로젝트, 구상, 조직 또는 개인에게 개발, 운영 또는 특정 목표 달성을 위해 제공되는 재정적 지원을 의미합니다. 1차 셀에서는 연구 프로젝트, 인력 지원, 장비 및 인프라, 교육 및 훈련, 규제 준수, 기술 개발 등을 지원하기 위해 정부 자금이 사용되고 있습니다. 예를 들어 2022년 5월, 미국에 본사를 둔 대규모 미국 암 연구 기관인 미국 암 연구소(AICR)는 2023년에 490억 달러의 자금 지원을 요청했는데, 이는 전년도 464억 달러에 비해 41억 달러 증가한 수치입니다. 따라서 암 연구에 대한 정부 자금 증가는 1차 세포 시장의 성장을 가속할 것으로 예측됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 일차 세포 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 일차 세포 시장 : 성장률 분석
세계의 일차 세포 시장 실적 : 규모와 성장, 2019-2024
세계의 일차 세포 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 일차 세포 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 일차 세포 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
조혈 세포
피부사상균
소화관 세포
간세포
폐세포
신장 세포
심장 세포
근골격 세포
기타 일차 세포
세계의 일차 세포 시장 : 기원별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
인간 일차 세포
동물 일차 세포
세계의 일차 세포 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품
바이오테크놀러지 기업
계약 조사기관(CRO)
학술연구기관
기타 최종사용자
세계의 일차 세포 시장 : 서브 세분화 조혈 세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
골수 유래 세포
말초혈 유래 세포
세계의 일차 세포 시장 : 서브 세분화 피부사상균(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
케라티노사이트
섬유아세포
세계의 일차 세포 시장 : 서브 세분화 소화관 세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
장관 상피 세포
배상 세포
파네트세포
세계의 일차 세포 시장 : 서브 세분화 간세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
간실질 세포
간성세포
세계의 일차 세포 시장 : 서브 세분화 폐세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
폐포 상피 세포
기관지 상피 세포
세계의 일차 세포 시장 : 서브 세분화 신장 세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
근위요세관 세포
사구체 세포
세계의 일차 세포 시장 : 서브 세분화 심장 세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
심근 세포
심장 섬유아세포
세계의 일차 세포 시장 : 서브 세분화 근골격 세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
근아세포
연골 세포
세계의 일차 세포 시장 : 서브 세분화 기타 일차 세포(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
내피세포
지방세포
제7장 지역별·국가별 분석
세계의 일차 세포 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 일차 세포 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
일차 세포 시장 : 경쟁 구도
일차 세포 시장 : 기업 개요
Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
BD Biosciences Overview, Products and Services, Strategy and Financial Analysis
Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
Cytiva Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Lonza Group Ltd
Charles River Laboratories Inc.
STEMCELL Technologies Inc
American Type Culture Collection
Cell Signaling Technology
BioIVT
InvivoGen
HemaCare Corporation
Creative Bioarray Inc.
PromoCell GmbH
CellGenix
AllCells LLC
Axol Bioscience Ltd
PBS Biotech Inc
AnaBios Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
일차 세포 시장 2029 : 새로운 기회를 제공하는 국가
일차 세포 시장 2029 : 새로운 기회를 제공하는 부문
일차 세포 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Primary cells refer to cells extracted directly from the living tissues of animals or people and then treated to prepare them for use in suitable cell treatments. These cells are employed in various applications, including 3D cell cultivation, virology, cancer research, stem cell treatment, and tissue restoration.
The main types of primary cells are hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and others. Hematopoietic cells are a type of stem cell that gives rise to the various blood cell types in the body. Its origins are human primary cells and animal primary cells, and its end users are pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The main types of primary cells are hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and others. Hematopoietic cells are a type of stem cell that gives rise to the various blood cell types in the body. Its origins are human primary cells and animal primary cells, and its end users are pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and others.
The primary cells market size has grown rapidly in recent years. It will grow from $1.49 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of cancer, increasing investments in regenerative medicine research, growing demand for monoclonal antibodies, advantages of primary human cells over cell lines, increasing prevalence of chronic diseases.
The primary cells market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing focus on stem cell research, rising investments, increasing adoption of cell-based assays. Major trends in the forecast period include demand for human primary cells, advancements in research tools and technologies, adoption of cell-based therapies.
The forecast of 10.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. biomedical research by increasing costs for high-quality primary cell lines imported from the UK and Canada, potentially compromising drug development timelines and raising lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising government funding for cancer research is expected to propel the growth of the primary cells market going forward. Funding refers to the financial support provided to a project, initiative, organization, or individual to enable its development, operation, or achievement of specific goals. Government funding is used in primary cells to support research projects, personnel support, equipment and infrastructure, training and education, regulatory compliance, and technology development. For instance, in May 2022, the American Institute for Cancer Research (AICR), a US-based large American cancer research organization, requested $49 billion funding in 2023, which is an increase of $4.1 billion compared to the previous year's $46.4 billion. Therefore, rising government funding for cancer research is expected to propel the growth of the primary cell market.
Leading companies in the primary cell market are focusing on innovations in cell products, including cell culture and stem cell products, to drive progress in research and therapeutic development. Serum-free medium, for example, is a type of growth medium for cell or tissue cultures that excludes animal-derived serums, such as fetal bovine serum (FBS). In July 2024, Bioserve Biotechnologies (India) Private Ltd., an Indian company specializing in biotechnology and life sciences solutions, introduced advanced stem cell products from REPROCELL to the Indian market. These new products aim to foster advancements in scientific research and drug development, contributing to growth in regenerative medicine and therapeutic discovery in the region.
In April 2023, AnaBios Corporation, a US-based biotechnology company, acquired Cell Systems for an undisclosed amount. This acquisition was aimed at expanding AnaBios' unique human tissue and cell portfolio, providing enhanced translational tools and reagents to academic, pharmaceutical, and biotech researchers, and optimizing research programs through enhanced human insights. Cell Systems is a US-based biotechnology company that specializes in providing human primary cells and cell culture media.
Major companies operating in the primary cells market are Thermo Fisher Scientific Inc, Merck KGaA, BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection, Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc
North America was the largest region in the primary cells market in 2024. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the primary cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary cells market consists of revenues earned by entities by providing services such as cell isolation services, primary cell culture services, cell characterization, and authentication. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary cell market also includes sales of cell culture media and reagents, cell culture plates and flasks, cell isolation kits, and transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Primary Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on primary cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for primary cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The primary cells market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Primary Cells Market Characteristics
3. Primary Cells Market Trends And Strategies
4. Primary Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Primary Cells Growth Analysis And Strategic Analysis Framework
5.1. Global Primary Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Primary Cells Market Growth Rate Analysis
5.4. Global Primary Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Primary Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Primary Cells Total Addressable Market (TAM)
6. Primary Cells Market Segmentation
6.1. Global Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Cells
Dermatophytes
Gastrointestinal Cells
Hepatocytes
Lung Cells
Renal Cells
Heart Cells
Musculoskeletal Cells
Other Primary Cells
6.2. Global Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Primary Cells
Animal Primary Cells
6.3. Global Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals
Biotechnology Companies
Contract Research Organizations (CRO)
Academic And Research Institutes
Other End Users
6.4. Global Primary Cells Market, Sub-Segmentation Of Hematopoietic Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Marrow-Derived Cells
Peripheral Blood-Derived Cells
6.5. Global Primary Cells Market, Sub-Segmentation Of Dermatophytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Keratinocytes
Fibroblasts
6.6. Global Primary Cells Market, Sub-Segmentation Of Gastrointestinal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enterocytes
Goblet Cells
Paneth Cells
6.7. Global Primary Cells Market, Sub-Segmentation Of Hepatocytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liver Parenchymal Cells
Hepatic Stellate Cells
6.8. Global Primary Cells Market, Sub-Segmentation Of Lung Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alveolar Epithelial Cells
Bronchial Epithelial Cells
6.9. Global Primary Cells Market, Sub-Segmentation Of Renal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proximal Tubular Cells
Glomerular Cells
6.10. Global Primary Cells Market, Sub-Segmentation Of Heart Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiomyocytes
Cardiac Fibroblasts
6.11. Global Primary Cells Market, Sub-Segmentation Of Musculoskeletal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Myoblasts
Chondrocytes
6.12. Global Primary Cells Market, Sub-Segmentation Of Other Primary Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endothelial Cells
Adipocytes
7. Primary Cells Market Regional And Country Analysis
7.1. Global Primary Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Primary Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Primary Cells Market
8.1. Asia-Pacific Primary Cells Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Primary Cells Market
9.1. China Primary Cells Market Overview
9.2. China Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Primary Cells Market
10.1. India Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Primary Cells Market
11.1. Japan Primary Cells Market Overview
11.2. Japan Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Primary Cells Market
12.1. Australia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Primary Cells Market
13.1. Indonesia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Primary Cells Market
14.1. South Korea Primary Cells Market Overview
14.2. South Korea Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Primary Cells Market
15.1. Western Europe Primary Cells Market Overview
15.2. Western Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Primary Cells Market
16.1. UK Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Primary Cells Market
17.1. Germany Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Primary Cells Market
18.1. France Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Primary Cells Market
19.1. Italy Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Primary Cells Market
20.1. Spain Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Primary Cells Market
21.1. Eastern Europe Primary Cells Market Overview
21.2. Eastern Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Primary Cells Market
22.1. Russia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Primary Cells Market
23.1. North America Primary Cells Market Overview
23.2. North America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Primary Cells Market
24.1. USA Primary Cells Market Overview
24.2. USA Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Primary Cells Market
25.1. Canada Primary Cells Market Overview
25.2. Canada Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Primary Cells Market
26.1. South America Primary Cells Market Overview
26.2. South America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Primary Cells Market
27.1. Brazil Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Primary Cells Market
28.1. Middle East Primary Cells Market Overview
28.2. Middle East Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Primary Cells Market
29.1. Africa Primary Cells Market Overview
29.2. Africa Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Primary Cells Market Competitive Landscape And Company Profiles
30.1. Primary Cells Market Competitive Landscape
30.2. Primary Cells Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. BD Biosciences Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Cytiva Overview, Products and Services, Strategy and Financial Analysis
31. Primary Cells Market Other Major And Innovative Companies
31.1. Lonza Group Ltd
31.2. Charles River Laboratories Inc.
31.3. STEMCELL Technologies Inc
31.4. American Type Culture Collection
31.5. Cell Signaling Technology
31.6. BioIVT
31.7. InvivoGen
31.8. HemaCare Corporation
31.9. Creative Bioarray Inc.
31.10. PromoCell GmbH
31.11. CellGenix
31.12. AllCells LLC
31.13. Axol Bioscience Ltd
31.14. PBS Biotech Inc
31.15. AnaBios Corporation
32. Global Primary Cells Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Primary Cells Market
34. Recent Developments In The Primary Cells Market
35. Primary Cells Market High Potential Countries, Segments and Strategies
35.1 Primary Cells Market In 2029 - Countries Offering Most New Opportunities
35.2 Primary Cells Market In 2029 - Segments Offering Most New Opportunities
35.3 Primary Cells Market In 2029 - Growth Strategies
